Evidence map›Paper›PMID 35180219›Full record

ArticlePLoS biology2022

The endoplasmic reticulum proteostasis network profoundly shapes the protein sequence space accessible to HIV envelope.

Jimin Yoon, Emmanuel E Nekongo, Jessica E Patrick, Tiffani Hui, Angela M Phillips, Anna I Ponomarenko, Samuel J Hendel, Rebecca M Sebastian, Yu Meng Zhang, Vincent L Butty and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jimin YoonDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-7010-082X
Emmanuel E NekongoDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Jessica E PatrickDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.ORCID 0000-0003-1450-6275
Tiffani HuiDepartment of Chemistry, Tufts University, Medford, Massachusetts, United States of America.
Angela M PhillipsDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-9806-7574
Anna I PonomarenkoDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Samuel J HendelDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Rebecca M SebastianDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Yu Meng ZhangDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Vincent L ButtyBioMicro Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.ORCID 0000-0003-1173-2429
C Brandon OgbunugaforDepartment of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, United States of America.ORCID 0000-0002-1581-8345
Yu-Shan LinDepartment of Chemistry, Tufts University, Medford, Massachusetts, United States of America.ORCID 0000-0001-6460-2877
Matthew D ShouldersDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-6511-3431
Massachusetts Institute of Technology · USTufts University · USYale University · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NILES, JACQUIN C · 1985 to 2020
$25.6M
Leveraging Next-Generation Directed Evolution Platforms and Chemical Control of Proteostasis to Deliver Robust Biotechnologies and Illuminate Roles of Chaperone Networks in Protein EvolutionR35GM136354 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHOULDERS, MATTHEW DONALD · 2020 to 2024
$2.1M
NCI NIH HHS P30 CA014051NIEHS NIH HHS P30 ES002109NIGMS NIH HHS R35 GM136354
6 · The paper itself

Abstract

The sequence space accessible to evolving proteins can be enhanced by cellular chaperones that assist biophysically defective clients in navigating complex folding landscapes. It is also possible, at least in theory, for proteostasis mechanisms that promote strict quality control to greatly constrain accessible protein sequence space. Unfortunately, most efforts to understand how proteostasis mechanisms influence evolution rely on artificial inhibition or genetic knockdown of specific chaperones. The few experiments that perturb quality control pathways also generally modulate the levels of only individual quality control factors. Here, we use chemical genetic strategies to tune proteostasis networks via natural stress response pathways that regulate the levels of entire suites of chaperones and quality control mechanisms. Specifically, we upregulate the unfolded protein response (UPR) to test the hypothesis that the host endoplasmic reticulum (ER) proteostasis network shapes the sequence space accessible to human immunodeficiency virus-1 (HIV-1) envelope (Env) protein. Elucidating factors that enhance or constrain Env sequence space is critical because Env evolves extremely rapidly, yielding HIV strains with antibody- and drug-escape mutations. We find that UPR-mediated upregulation of ER proteostasis factors, particularly those controlled by the IRE1-XBP1s UPR arm, globally reduces Env mutational tolerance. Conserved, functionally important Env regions exhibit the largest decreases in mutational tolerance upon XBP1s induction. Our data indicate that this phenomenon likely reflects strict quality control endowed by XBP1s-mediated remodeling of the ER proteostasis environment. Intriguingly, and in contrast, specific regions of Env, including regions targeted by broadly neutralizing antibodies, display enhanced mutational tolerance when XBP1s is induced, hinting at a role for host proteostasis network hijacking in potentiating antibody escape. These observations reveal a key function for proteostasis networks in decreasing instead of expanding the sequence space accessible to client proteins, while also demonstrating that the host ER proteostasis network profoundly shapes the mutational tolerance of Env in ways that could have important consequences for HIV adaptation.

Indexed as

HIV InfectionsProteostasisEndoplasmic ReticulumEndoplasmic Reticulum StressHumansMolecular ChaperonesUnfolded Protein ResponseMolecular Chaperones

Identifiers

PMID35180219
PMCPMC8906867
OpenAlexW4213098460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.